Crossmark

Bio-efficacy of Olyset® Plus, PermaNet® 3.0 and Interceptor® G2 on pyrethroid-resistant populations of Anopheles gambiae s.l. prior to the June 2023 net distribution campaign in Benin, West Africa

Crossref DOI link: https://doi.org/10.1186/s41182-024-00599-z

Published Online: 2024-04-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zoungbédji, David Mahouton https://orcid.org/0009-0007-3919-5027
Padonou, Germain Gil

Sovi, Arthur

Konkon, Alphonse Keller

Salako, Albert Sourou

Azondékon, Roseric

Sidick, Aboubakar

Ahouandjinou, Juvénal Minassou

Towakinou, Linda

Ossè, Razaki

Aïkpon, Rock

Affoukou, Cyriaque

Baba-Moussa, Lamine

Akogbéto, Martin
License Information

Text and Data Mining valid from 2024-04-30

Version of Record valid from 2024-04-30
More Information

Article History

Received: 2 February 2024

Accepted: 17 April 2024

First Online: 30 April 2024

Declarations

:

: Not applicable.

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below